H. Lundbeck A/S
🇩🇰Denmark
- Country
- 🇩🇰Denmark
- Ownership
- Public, Subsidiary
- Established
- 2000-01-01
- Employees
- 5.6K
- Market Cap
- -
- Website
- http://www.lundbeck.com
Electroencephalography Study Investigating the Effects of Vortioxetine in Healthy Male Subjects
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2014-02-26
- Last Posted Date
- 2015-09-01
- Lead Sponsor
- H. Lundbeck A/S
- Target Recruit Count
- 32
- Registration Number
- NCT02072278
- Locations
- 🇫🇷
FR801, Rennes, France
Absolute Bioavailability of Lu AE58054 in Healthy Subjects
- First Posted Date
- 2013-12-24
- Last Posted Date
- 2014-03-21
- Lead Sponsor
- H. Lundbeck A/S
- Target Recruit Count
- 10
- Registration Number
- NCT02019394
- Locations
- 🇬🇧
GB803, Nottingham, United Kingdom
Idalopirdine in Patients With Mild-moderate Alzheimer's Disease Treated With Donepezil
- First Posted Date
- 2013-12-10
- Last Posted Date
- 2018-02-20
- Lead Sponsor
- H. Lundbeck A/S
- Target Recruit Count
- 858
- Registration Number
- NCT02006641
- Locations
- 🇮🇱
IL302, Haifa, Israel
🇺🇸US305, Carson, California, United States
🇺🇸US346, Costa Mesa, California, United States
Study of Idalopirdine in Patients With Mild - Moderate Alzheimer's Disease Treated With an Acetylcholinesterase Inhibitor
- First Posted Date
- 2013-12-10
- Last Posted Date
- 2018-02-07
- Lead Sponsor
- H. Lundbeck A/S
- Target Recruit Count
- 734
- Registration Number
- NCT02006654
- Locations
- 🇺🇸
US608, Deerfield Beach, Florida, United States
🇩🇪DE616, Unterhaching, Germany
🇩🇪DE601, Munich, Germany
Brexpiprazole as an Adjunctive Treatment to Paroxetine or Sertraline in Adult Patients Suffering From Post-traumatic Stress Disorder (PTSD)
Phase 3
Terminated
- Conditions
- Interventions
- First Posted Date
- 2013-11-20
- Last Posted Date
- 2017-03-13
- Lead Sponsor
- H. Lundbeck A/S
- Target Recruit Count
- 417
- Registration Number
- NCT01987960
- Locations
- 🇵🇱
PL002, Lublin, Poland
🇫🇮FI004, Turku, Finland
🇫🇮FI002, Helsinki, Finland
Study Investigating the Safety, Tolerability, and Pharmacokinetic Properties of Lu AE58054 in Healthy Japanese and Caucasian Subjects
Phase 1
Completed
- Conditions
- First Posted Date
- 2013-11-05
- Last Posted Date
- 2013-11-05
- Lead Sponsor
- H. Lundbeck A/S
- Target Recruit Count
- 42
- Registration Number
- NCT01975779
- Locations
- 🇬🇧
GB001, London, United Kingdom
Effects of Nalmefene After Single Dose on the Blood Oxygen Level Dependent (BOLD) fMRI Signal in the Ventral Striatum to Reward Responding in the Monetary Incentive Delay Task (MIDT), in Non-treatment Seeking Subjects With Alcohol Dependence Following Alcohol Challenge
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2013-10-25
- Last Posted Date
- 2014-11-11
- Lead Sponsor
- H. Lundbeck A/S
- Target Recruit Count
- 22
- Registration Number
- NCT01969617
- Locations
- 🇬🇧
GB801, London, United Kingdom
Aripiprazole Once-monthly in Patients With Schizophrenia
- First Posted Date
- 2013-10-09
- Last Posted Date
- 2017-03-17
- Lead Sponsor
- H. Lundbeck A/S
- Target Recruit Count
- 88
- Registration Number
- NCT01959035
- Locations
- 🇺🇸
US006, San Diego, California, United States
Study of Idalopirdine in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil
- First Posted Date
- 2013-10-07
- Last Posted Date
- 2017-09-19
- Lead Sponsor
- H. Lundbeck A/S
- Target Recruit Count
- 933
- Registration Number
- NCT01955161
- Locations
- 🇺🇸
US043, Staten Island, New York, United States
🇺🇸US002, Los Angeles, California, United States
🇺🇸US042, Boca Raton, Florida, United States
Long-term Safety and Tolerability Study of Brexpiprazole as Adjunctive Treatment in Patients With Major Depressive Disorder
- First Posted Date
- 2013-09-18
- Last Posted Date
- 2018-10-17
- Lead Sponsor
- H. Lundbeck A/S
- Target Recruit Count
- 26
- Registration Number
- NCT01944969
- Locations
- 🇺🇸
US008, Orlando, Florida, United States
© Copyright 2024. All Rights Reserved by MedPath